Pricing Log in Create free account

Avenue Therapeutics, Inc. (ATXI) vs Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX)

Avenue Therapeutics, Inc. and Biodexa Pharmaceuticals PLC Unsponsored ADR are both Biotechnology companies. Avenue Therapeutics, Inc. is the larger, with a market value of $680.0K against $440.0K — 1.5× the size. Avenue Therapeutics, Inc. has the higher net margin (0.00% vs −1,155.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, Avenue Therapeutics, Inc. leads on 5 and Biodexa Pharmaceuticals PLC Unsponsored ADR on 4.

Valuation

Metric ATXI BDRX Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 2.49 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.05 0.20 0.64
EV/Sales n/m (2.81) 9.21
Earnings yield (197.67%) (555.04%) (33.15%)
Free cash flow yield (97.68%) 0.00% (25.50%)

Profitability

Metric ATXI BDRX Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (1,155.70%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (163.30%) 0.00% (56.36%)
Return on assets (90.50%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATXI BDRX Biotechnology median
Revenue growth (TTM) — 60.22% 6.02%
EPS growth (last fiscal year) 89.70% 89.68% 30.26%
Revenue growth, 5-year CAGR — (28.78%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATXI BDRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.40 2.41 4.72
Net debt to EBITDA 0.93 1.00 0.96

Dividend

Metric ATXI BDRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ATXI BDRX Biotechnology median
Market cap 680.00k 440.00k 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack